SSR4 and esophageal squamous cell carcinoma: Survival analysis showcased that SSR4 overexpression was significantly associated with OS and shorter disease-free survival (DFS; P = 0.016 and P = 0.0286, respectively), indicating that patients who have ESCC with overexpressed SSR4 have a poor prognosis (Figures 2C, D).